Cumberland Pharmaceuticals Files 8-K on Financials
Ticker: CPIX · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1087294
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: CPRX
TL;DR
CPRX dropped an 8-K detailing financial results - check it out.
AI Summary
Cumberland Pharmaceuticals Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing details the company's financial performance and provides supporting documentation.
Why It Matters
This filing provides investors with crucial updates on Cumberland Pharmaceuticals' financial health and operational results, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- CUMBERLAND PHARMACEUTICALS INC (company) — Registrant
- August 5, 2025 (date) — Date of Report
- 20250805 (date) — Conformed Period of Report
FAQ
What specific financial information is being reported in this 8-K?
The 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filed?
This 8-K was filed on August 5, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 1600 West End Avenue, Suite 1300, Nashville, Tennessee 37203.
What is Cumberland Pharmaceuticals Inc.'s SIC code?
The Standard Industrial Classification (SIC) code for Cumberland Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding CUMBERLAND PHARMACEUTICALS INC (CPIX).